Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(4'-methylaminophenyl)benzothiazole
1. Bta-1
2. 439858-28-3
3. 4-(benzo[d]thiazol-2-yl)-n-methylaniline
4. 2-(4'-methylaminophenyl)benzothiazole
5. Bta-eg4
6. Chembl93334
7. 921193-28-4
8. 2-(4-methylaminophenyl)benzothiazole
9. Schembl493341
10. Zinc9200
11. Dtxsid90431602
12. Bdbm50109052
13. Akos003383867
14. Hy-w278021
15. Bta-1, >=98% (hplc), Solid
16. Ncgc00165760-01
17. (4-benzothiazol-2-yl-phenyl)-methyl-amine
18. Cs-0323149
19. [4-(1,3-benzothiazol-2-yl)phenyl]methylamine
20. 10.14272/fhjrkgxjbxpbga-uhfffaoysa-n.1
21. 6x-7042
22. 858b283
23. Doi:10.14272/fhjrkgxjbxpbga-uhfffaoysa-n.1
| Molecular Weight | 240.33 g/mol |
|---|---|
| Molecular Formula | C14H12N2S |
| XLogP3 | 4.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 240.07211956 g/mol |
| Monoisotopic Mass | 240.07211956 g/mol |
| Topological Polar Surface Area | 53.2 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 251 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Benzo-Thiazole-Aniline-1-Methyl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Benzo-Thiazole-Aniline-1-Methyl, including repackagers and relabelers. The FDA regulates Benzo-Thiazole-Aniline-1-Methyl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Benzo-Thiazole-Aniline-1-Methyl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Benzo-Thiazole-Aniline-1-Methyl supplier is an individual or a company that provides Benzo-Thiazole-Aniline-1-Methyl active pharmaceutical ingredient (API) or Benzo-Thiazole-Aniline-1-Methyl finished formulations upon request. The Benzo-Thiazole-Aniline-1-Methyl suppliers may include Benzo-Thiazole-Aniline-1-Methyl API manufacturers, exporters, distributors and traders.
click here to find a list of Benzo-Thiazole-Aniline-1-Methyl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Benzo-Thiazole-Aniline-1-Methyl DMF (Drug Master File) is a document detailing the whole manufacturing process of Benzo-Thiazole-Aniline-1-Methyl active pharmaceutical ingredient (API) in detail. Different forms of Benzo-Thiazole-Aniline-1-Methyl DMFs exist exist since differing nations have different regulations, such as Benzo-Thiazole-Aniline-1-Methyl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Benzo-Thiazole-Aniline-1-Methyl DMF submitted to regulatory agencies in the US is known as a USDMF. Benzo-Thiazole-Aniline-1-Methyl USDMF includes data on Benzo-Thiazole-Aniline-1-Methyl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Benzo-Thiazole-Aniline-1-Methyl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Benzo-Thiazole-Aniline-1-Methyl suppliers with USDMF on PharmaCompass.
Benzo-Thiazole-Aniline-1-Methyl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Benzo-Thiazole-Aniline-1-Methyl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Benzo-Thiazole-Aniline-1-Methyl GMP manufacturer or Benzo-Thiazole-Aniline-1-Methyl GMP API supplier for your needs.
A Benzo-Thiazole-Aniline-1-Methyl CoA (Certificate of Analysis) is a formal document that attests to Benzo-Thiazole-Aniline-1-Methyl's compliance with Benzo-Thiazole-Aniline-1-Methyl specifications and serves as a tool for batch-level quality control.
Benzo-Thiazole-Aniline-1-Methyl CoA mostly includes findings from lab analyses of a specific batch. For each Benzo-Thiazole-Aniline-1-Methyl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Benzo-Thiazole-Aniline-1-Methyl may be tested according to a variety of international standards, such as European Pharmacopoeia (Benzo-Thiazole-Aniline-1-Methyl EP), Benzo-Thiazole-Aniline-1-Methyl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Benzo-Thiazole-Aniline-1-Methyl USP).
LOOKING FOR A SUPPLIER?
